Assessing Medpace Hldgs: Insights From 9 Financial Analysts
Assessing Medpace Hldgs: Insights From 9 Financial Analysts
评估medpace控股:来自9位财务分析师的见解
In the latest quarter, 9 analysts provided ratings for Medpace Hldgs (NASDAQ:MEDP), showcasing a mix of bullish and bearish perspectives.
在最新的季度中,有9位分析师为Medpace Hldgs(纳斯达克:MEDP)提供了评级,展示了一种看好和看淡的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您将找到他们最近的评级摘要,揭示了过去30天内情绪的变化,并将它们与前几个月进行比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $402.67, a high estimate of $469.00, and a low estimate of $336.00. A decline of 7.99% from the prior average price target is evident in the current average.
分析师通过对12个月价格目标的评估提供更深入的见解,显示出平均目标为$402.67,高估为$469.00,低估为$336.00。从先前的平均价格目标下降了7.99%,当前平均价格目标可见。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
A clear picture of Medpace...
通过对最近...
登录免费看全文
登录/注册